Contreras LS , Lugo PA , Palacios CI , Canseco ÁL , Gómez CO , Lozano OJ , Gómez CR , Figueroa GP , Bermúdez AN , Serrano GE

Language: Spanish
References: 6
Page: 95-98
PDF size: 794.68 Kb.

ABSTRACT

The nasoangiofibroma occurs almost exclusively in adolescent males and corresponds to 0.5-0.05% of all head and neck tumors, varying this number in some Asian and African countries. This case corresponds to the description of a nasoangiofibroma treated and documented in the Hospital Regional de Alta Especialidad Ciudad Salud. Because it is a highly vascular tumor and surgical resection has a high risk for trans and postoperative bleeding, a decision was taken to selectively embolize the tumor; after 24 hours the patient underwent surgery and was discharged 96 hours later.

REFERENCES

1. Ramírez J, Amado S. Abordaje endoscópico de la fosa pterigomaxilar (nasoangiofibroma juvenil). Acta Otorrinolaringol Cir Cab Cuello 2004; 32: 101-109.

2. Dillard DG, Cohen C, Muller S, Del Gaudio J, Reichman O, Parrish B, Rackley D, Gal AA. Immunolocalization of activated transforming growth factor 1 in juvenile nasopharyngeal angiofibrom. Arch Otolaryngol Head Neck Surg 2000; 126: 723-725.

3. Sánchez de Guzmán G. Experiencia en el manejo de nasoangiofibroma juvenil en el Instituto Nacional de Cancerología. Acta Otorrinolaringol Cir Cab Cuello 1999; 27 (3).

4. Gaceta MM. Nasoangiofibroma juvenil: frecuencia. Incidencia de acuerdo al grupo sanguíneo. An ORL Mex 2005; 50: 17-21.

5. Wylie JP, Slevin NJ, Johnson RJ. Intracraneal juvenile nasopharyngeal angiofibroma. Clin Oncol 1998; 10: 330-333.

6. Sociedade Brasileira de Otorrinolaringologia. Tratado de otorrinolaringología. Brasil: Editorial Roca LTDA; 2003; 701-711.